Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin

NCT02677389 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-11-18

No results posted yet for this study

Summary

This randomized pilot clinical trial studies how well survivorship care plan works in promoting technology-based physical activity in breast or colorectal cancer survivors in Wisconsin. A survivorship care plan may help doctors to better understand how they can help people who have been diagnosed with cancer to become more physically active. It is not yet known whether a standardized cancer survivor plan used as part of routine care or a technology-based physical activity intervention is better in promoting physical activity in breast or colorectal cancer survivors.

Conditions

  • Cancer Survivor
  • Healthy Subject
  • Stage I Colorectal Cancer
  • Stage IA Breast Cancer
  • Stage IB Breast Cancer
  • Stage IIA Breast Cancer
  • Stage IIA Colorectal Cancer
  • Stage IIB Breast Cancer
  • Stage IIB Colorectal Cancer
  • Stage IIC Colorectal Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIA Colorectal Cancer
  • Stage IIIB Breast Cancer
  • Stage IIIB Colorectal Cancer
  • Stage IIIC Breast Cancer
  • Stage IIIC Colorectal Cancer

Interventions

OTHER

Educational Intervention

Receive educational material regarding physical activity and standardized emails with wellness tips and information on stress management

OTHER

Internet-Based Intervention

Receive email and technical or how-to support from study coordinator

DEVICE

Monitoring Device

Wear a Fitbit web-integrated physical activity tracker

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Lisa Cadmus-Bertram · University of Wisconsin, Madison

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2018-01-24
Completion
2018-01-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02677389 on ClinicalTrials.gov